Noted for its 'prompt service, technical capacity and negotiation skills', Mattos Filho handles regulatory, contractual and litigation matters for a diverse group of life sciences and healthcare players. Pharmaceutical, biotechnology, healthtech, food and beverages, and medical device companies regularly turn to the team for advice on the gamut of industry-related matters, including corporate transactions, clinical trials, product development and pricing. Practice head Ana Cândida Sammarco is singled out for her experience in life sciences regulatory issues; she regularly advises on the structuring of healthcare plan agreements, implementation of new technologies, and drafting and negotiating supply and distribution agreements. Fellow co-leader Gustavo Swenson Caetano utilises his IP and food law expertise to handle contractual, commercial and transactional work in the life sciences sector.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • ‘Mattos Filho has a fine and solid life sciences team.’

  • ‘Mattos Filho life sciences' practice is led by Ana Candida, who stands out in the Brazilian market.’

  • 'Prompt service, technical capacity and negotiation skills are what makes the firm stand out. The partners always meet the challenging deadlines we give them, with quality and promptness. The trust created is the strongest element in the their relationship with the client.'
  • 'Gustavo Swenson Caetano and Ana Cândida Sammarco are recommended.'
  • 'The life sciences practice at Mattos Filho serves clients excellently and without leaving anything to be desired in any aspect whatsoever. In several opportunities to discuss contracts or in negotiations, it brings innovative and differentiated alternatives, which leads the negotiation to a satisfactory path not only for the client, but also for the counterparty. The service is always above expectations.'
  • 'The life sciences team is extremely competent and committed, with partner Gustavo Swenson Caetano leading the main negotiations. Ana Cândida excels in strategic situations.'
  • 'The life sciences team, led by partner Gustavo Caetano, has a lot of knowledge in the regulatory area and navigates the companies' businesses well. It is also knowledgeable of regulatory matters in other reference countries, and able to present a more comprehensive assessment of the topic in connection with other jurisdictions.'

Key clients

  • Fresenius-Kabi Brazil, Fresenius-Kabi Swissbiossimilar and Fresenius-Kabi
  • Amgen
  • Laboratórios Pfizer
  • Sanofi Farmacêutica
  • Hypera Pharma
  • Roche
  • DASA Diagnósticos da América
  • Aché
  • Establishment Labs
  • Grupo DPSP – Drogaria São Paulo
  • DIMED – Drogaria Panvel
  • RaiaDrogasil
  • Daiichi Sankyo
  • Terumo Medical
  • Oxitec
  • Petz
  • Akzo Nobel
  • Meta Platforms
  • Associação Educadora São Carlos - Mãe de Deus Hospital

Work highlights

  • Advising Fresenius and its Brazilian subsidiary on the negotiation of a productive development partnership.
  • Advises Farmax on a wide range of regulatory matters, including interactions with ANVISA and local sanitary authorities due to a previous sanitary inspection and existing recall administrative proceeding.
  • Assisting Hypera with regulatory and contractual-related matters.

Lawyers

Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.

Practice head

The lawyer(s) leading their teams.

Ana Cândida Sammarco, Gustavo Swenson Caetano